NIKKEI 225
32,371.90 +56.85 (+0.18%) HANG SENG
17,611.87 +144.97 (+0.83%) CRUDE OIL
93.47 +3.08 (+3.41%) GOLD FUTURES
1,892.80 -27.00 (-1.41%) DOW
33,374.10 -244.78 (-0.73%) Bitcoin GBP
21,620.48 +28.21 (+0.13%)
Pfizer Inc. (PFE)
- Motley Fool
Why Ginkgo Bioworks Stock Is Surging Higher Today
Ginkgo Bioworks (NYSE: DNA) is having a strong showing today. Specifically, the synthetic biology company's shares were up by 10.1% on heavy volume as of 9:57 a.m. ET Wednesday morning. Ahead of the opening bell, Ginkgo Bioworks announced an RNA-based drug development collaboration with biopharma heavyweight Pfizer (NYSE: PFE).
- Motley Fool
These 2 Stocks Are Getting Smart Investors' Attention Wednesday
On Wednesday morning, NextEra Energy Partners (NYSE: NEP) was among the biggest decliners, while Ginkgo Bioworks (NYSE: DNA) got a nice boost. Smart investors are noticing these two companies and want to know what's justifying the moves. Here's your opportunity to be in the know and learn more about NextEra and Ginkgo.
- Zacks
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
